User login
Congenital Hyperinsulinism International (CHI) has issued a statement encouraging widespread adoption of recommendations published recently by the Pediatric Endocrine Society regarding evaluation and management of persistent hypoglycemia in neonates, infants, and children. In a survey conducted by CHI, 60% of the infants with congenital hyperinsulinism were not diagnosed during the newborn period. Failure to identify this condition can lead to brain damage or death. To read more: https://www.pedsendo.org/education_training/healthcare_providers/consensus_statements/assets/PES_recommendation_hypoglycemia.pdf
Congenital Hyperinsulinism International (CHI) has issued a statement encouraging widespread adoption of recommendations published recently by the Pediatric Endocrine Society regarding evaluation and management of persistent hypoglycemia in neonates, infants, and children. In a survey conducted by CHI, 60% of the infants with congenital hyperinsulinism were not diagnosed during the newborn period. Failure to identify this condition can lead to brain damage or death. To read more: https://www.pedsendo.org/education_training/healthcare_providers/consensus_statements/assets/PES_recommendation_hypoglycemia.pdf
Congenital Hyperinsulinism International (CHI) has issued a statement encouraging widespread adoption of recommendations published recently by the Pediatric Endocrine Society regarding evaluation and management of persistent hypoglycemia in neonates, infants, and children. In a survey conducted by CHI, 60% of the infants with congenital hyperinsulinism were not diagnosed during the newborn period. Failure to identify this condition can lead to brain damage or death. To read more: https://www.pedsendo.org/education_training/healthcare_providers/consensus_statements/assets/PES_recommendation_hypoglycemia.pdf
